Skip to main content

Canopy Rivers Inc., the venture capital arm of cannabis company Canopy Growth Corp., reported a net loss of nearly $3-million in its latest quarter.

The company says the loss amounted to two cents per diluted share for the quarter ended June 30, compared with a net loss of $6.6-million or five cents a share a year ago.

Operating income in what was the first quarter of the company’s 2020 financial year totalled $2.7-million, up from $744,000, including royalty, interest and lease income.

Story continues below advertisement

During the quarter, Canopy Rivers made $18.8-million in new investments in High Beauty, Biolumic and Zeakal.

The company also contributed a total of $6.0-million to existing investees Agripharm and Greenhouse Juice Co.

Canopy Rivers holds a diversified portfolio of 18 companies in the cannabis sector.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter